Cytokinetics OverviewCytokinetics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CYTK.
Quarterly EBIT
-$187.00M
↓ 37.37% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$759.99M
↓ 42.18% YoY
Trailing 12 months ending Mar 31, 2026
Cytokinetics OverviewEBIT (Earnings Before Interest and Taxes) analysis for CYTK.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026